baber/WOPTO huggingface dataset:
Patent JP-H0729017-B2 (JP)
IPC: F02M35/024
Filed: 1991-01-23
Abstract: A filter element made of non-woven fabric formed as a folded package is self-supporting and is composed of thermally sealable non-woven fabric (1). Each of the two outer edges (3) of the folded package (2) is lined by the non-woven fabric material (1) forming the folds (4), which material, at each folded edge (3), is folded over in the same direction and is fixed to the corresponding bent edge of the adjacent end of fold in a tight fitting manner. The non-woven fabric material overlaps each bent edge of the adjacent end of fold by 1.5 to 2.5 times the fold separation. 
<??>To produce the filter element, the flat filter medium (1) is first folded and then a defined fold separation (7) is produced by a limited stretching perpendicular to the folding. The two outer edges (8) of the folded package are then positively clamped into comb-like sections (9) corresponding to the geometry and dimensions of the folds, and penetrating pincer-like into the folds on the upper and lower sides, the filter material projecting over the shaped sections (9) on each side by 1.5 to 2.5 times the fold separation (7). The overlapping material (10) is folded down on both sides in each case by means of a first pressing element (11) having a sideways action thereon, until the overlapping material (10) fits on the adjacent end of fold, so that the edges overlap. Energy allowing thermal sealing is supplied via these pressing elements (11). Further subsequent pressing elements (12) fix the sealed sites during cooling. The comb-like sections (9) are then removed and the folded package is contracted. 
<IMAGE>
Patent JP-S6313377-B2 (JP)
IPC: H04B7/005
Filed: 1982-01-19
Abstract: PURPOSE:To correct the rainfall attenuation of an up link without wasting the transmitting electric power of a satellite and increasing the scale of a ground station by allowing a subordinate station to receive a pilot signal from a master station and controlling the transmitting electric power of the subordinate station individually according to the received level. CONSTITUTION:When a maximum received level on a fine weather condition is PA, it is the set level of this circuit. At the master station, a common-circuit (CSC circuit) carrier received level from each subordinate station is sampled and a level comparison is made to transmit the pilot signal by increasing the transmitting electric power up to the received level of a station having the highest received level. Since the effective isotropic radiation electric power (EIRP) of the satellite is constant without reference to rainfall attenuation near the master station, i.e. transmitting station, each subordinate station controls its transmitting electric power so that the received level of its own radio wave is equal to that of a pilot signal received by itself, thus making the EIRP constant without reference to the rainfall attenuation.
Patent AU-563591-B2 (AU)
Title: Pyrazolo/4,3-c/pyridines
Inventor: WINTERS GIORGIO
IPC: C07D471/04
Filed: 1983-02-10
Granted: 1987-07-16
Abstract: The present invention is directed to new pyrazolo/4,3- c/pyridines, the process for their preparation, the pharmaceutical compositions containing them and their use as pharmocologically active substances. The compounds of the invention possess cardiotonic, antihypertensive, CNS depressant, neuroleptic, and analgesic activity.
Patent AU-563732-B2 (AU)
Title: 1,24-triazoyl(imidazolyl)-alicyclic alcohols
Inventor: GRAVESTOCK MICHAEL BARRY
IPC: C07D249/08
Filed: 1983-03-30
Granted: 1987-07-23
Abstract: This invention relates to novel alicyclic alcohol compounds of the formula  <IMAGE>  wherein Az is imidazole or 1,2,4-triazole, R6 is optionally substituted phenyl and A is an alicyclic ring optionally benzo-fused, which compounds possess pharmaceutical, veterinary, agricultural and horticultural antifungal properties; together with a process for their manufacture, compositions containing them, and a method of combatting plant fungal diseases.
Patent AU-696753-B2 (AU)
Title: Workstation communication system
Inventor: BERTSCH GUNTER
IPC: H04N7/15
Filed: 1995-03-06
Granted: 1998-09-17
Abstract: The communication system has at least one first work station (A1) with a display monitor (D1) having a touch-sensitive surface, a data processor (PC1), a camera (C1) and an interface for connection to an integrated services digital network (ISDN), allowing transmission of speech, image and/or document data. The network is coupled to a second work station (A2), with a similar display (D2) and camera (C2) and a main processor (PC2) with a keyboard (T), used for preparation of documents and for programming. Pref. a third work station acts as a server with a touch-sensitive writing surface for information input and a number of displays and associated cameras, corresponding to the number of served work stations.
Patent AU-602394-B2 (AU)
Title: Process for creating a skin substitute and the resulting skin substitute
Inventor: BERNARD BRUNO
IPC: C12N5/00
Filed: 1988-03-25
Granted: 1990-10-11
Abstract: The method for obtaining a skin equivalent (27) involves preparing a dermis equivalent (24) by mixing contractile cells, a nutrient medium and collagen so as to form a gel which contracts; using this dermis equivalent (24) as a substrate for an epidermis equivalent (26) obtained by sowing with the keratinocytes from an animal or human explant. According to the invention, the substrate (24) is sown with at least one section of a hair follicle (22) comprising at least partially its cellular sheath, the said section being implanted substantially perpendicular to the free surface of the substrate. <IMAGE>
Patent AU-709861-B2 (AU)
Title: Fluid delivery device
Inventor: SHINE THOMAS ADAM
IPC: F04B9/04
Filed: 1996-12-27
Granted: 1999-09-09
Abstract: PCT No. PCT/GB96/03258 Sec. 371 Date Aug. 4, 1998 Sec. 102(e) Date Aug. 4, 1998 PCT Filed Dec. 27, 1996 PCT Pub. No. WO97/24529 PCT Pub. Date Jul. 10, 1997A fluid delivery apparatus comprising two or more delivery syringes (17), each delivery syringe comprising a syringe housing (18) defining a tube with a passage having a fluid outlet, and a syringe plunger arranged to slide axially within the tubular passage and seal one end of the tubular passage. The apparatus also includes a syringe plunger drive arranged to drive the syringe plunger along at least part of the length of the tubular passage according to a predetermined velocity profile or the delivery syringe and discharge fluid through the fluid outlet. The predetermined velocity profile of each delivery syringe is such that, in use, a combined flow rate fluid discharge simultaneously from the outlets from the delivery syringes is maintained substantially constant over at least a quarter of the range of movement of each of the plungers. In a preferred example, the syringe plunger drive comprises a rotatable cam (2) and a cam follower (14), being coupled to the syringe plunger to drive the syringe plunger as the cam is rotated.
Patent AU-562743-B2 (AU)
Title: Zeolite catalytic dewaxing process
Inventor: LAPIERRE RENE BERNARD
IPC: C10G45/64
Filed: 1983-05-09
Granted: 1987-06-18
Abstract: Hydrocarbon feedstocks such as distillate fuel oils and gas oils are dewaxed by isomerizing the waxy components over a zeolite beta catalyst. The process may be carried out in the presence or absence of added hydrogen. Preferred catalysts have a zeolite silica:alumina ratio over 100:1.
Patent AU-664701-B2 (AU)
Title: Electronic book
Inventor: MCTAGGART STEPHEN I
IPC: G09B5/06
Filed: 1992-04-14
Granted: 1995-11-30
Abstract: PCT No. PCT/US92/03056 Sec. 371 Date Oct. 15, 1993 Sec. 102(e) Date Oct. 28, 1993 PCT Filed Apr. 14, 1992 PCT Pub. No. WO92/18964 PCT Pub. Date Oct. 29, 1992.An electronic book apparatus that comprises multiple pages (122) with printed information (126), a visual signal (125) for identifying the printed information in a sequentially organized manner, a synchronized audio signal (154) for describing and further identifying the information concurrently with the visual signal, and a switch (127) for electronically controlling the generation and transmission of these signals when each particular page is opened for viewing. Each page of the electronic book includes a laminated sheet (124), on which the printed material is arranged, and an electronic backdrop (121) containing the visual signal for display through the laminated sheet. Separate intelligent electronics (160) in the spine (140) and top portion (150) of the book, coupled to the a switch, activate the illuminating circuitry and a voice synthesizer (168) that are synchronized and sequenced to produce a concurrent visual and audio enhancement of the printed matter being viewed on the page.
Patent AU-729279-B2 (AU)
Title: APO-2 ligand
Inventor: ASHKENAZI AVI J
IPC: A61P13/10
Filed: 1997-01-08
Granted: 2001-02-01
Abstract: A cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided. The Apo-2 ligand is believed to be a member of the TNF cytokine family. Compositions including Apo-2 ligand chimeras, nucleic acid encoding Apo-2 ligand, and antibodies to Apo-2 ligand are also provided. Methods of using Apo-2 ligand to induce and to treat pathological conditions such as cancer, are further provided.
Patent AU-553816-B2 (AU)
Title: Fire extinguishing system
Inventor: MILLER WALTER G
IPC: A62C35/02
Filed: 1983-09-20
Granted: 1986-07-31
Abstract: The disclosure herein describes a system for extinguishing fires which consists in first maintaining a supply of liquid fire extinguishing medium in a tank under a pressure cushion of expellant material; the medium is delivered upon detection of a hazard by opening a normally closed valve in a delivery line connected to the tank; this operation triggers a sequential operation of a plurality of groups of expellant containers which causes additional expellant material to be delivered to the tank to maintain therein a given pressure so as to effect quick and total evacuation of the fire extinguishing medium from the tank to the hazard.
Patent AU-709645-B2 (AU)
Title: Methods and compositions useful for inhibition of angiogenesis
Inventor: BROOKS PETER
IPC: A61K39/00
Filed: 1995-03-09
Granted: 1999-09-02
Abstract: Angiogenesis is inhibited in a tissue by admin. of a compsn. comprising an alpha vbeta 3 antagonist.
Patent AU-651710-B2 (AU)
Title: Bidirectional valved catheter
Inventor: FENTON PAUL V JR
IPC: A61M1/00
Filed: 1992-05-11
Granted: 1994-07-28
Abstract: A valved catheter is disclosed having an elongated, flexible tubular element defining a lumen extending along an axis substantially parallel to the central axis of the tubular element, and a bidirectional check valve assembly near its distal end which controls fluid flow in the tubular element. The valve assembly includes an aspiration valve offset from the tip of the distal end and an infusion valve formed at the tip of the distal end. The aspiration valve is generally defined by port(s) in the tubular element and a sleeve within the element underlying the ports, where the sleeve normally closes the ports. The aspiration valve permits fluid flow from the bloodstream into the element when the static fluid pressure inside the distal end is lower than the static fluid pressure outside the aspiration valve by an amount sufficient to displace the sleeve to allow fluid flow through the ports. The infusion valve includes a throat formed in the distal end which tapers down to a mouth formed by jaws at the tip. The mouth is essentially closed to fluid inflow from the patient into the tubular element and normally closed to fluid outflow from the tubular element into the patient. The infusion valve permits fluid infusion into the bloodstream when the static fluid pressure inside of the tubular element sidtal end is higher than the static fluid pressure outside of the infusion valve by an amount sufficient to force the mouth open. A bidirectionally valved multiple lumen catheter is also disclosed.
Patent AU-565734-B2 (AU)
Title: Thermo-corsslinking light sensitive composition
Inventor: HSIEH SHANE
IPC: G03C1/72
Filed: 1983-12-02
Granted: 1987-09-24
Abstract: 1. A light-sensitive composition which comprises a water-insoluble binder which is soluble in aqueous-alkaline solutions ; and a light-sensitive component selected from the group consisting of o- or p- quinone diazides, diazonium salt polycondensation products, or a mixture of a) a compound which eliminates an acid on exposure to light and b) a compound having at least one C-O-C group which can be split by acid ; and a thermo-crosslinking compound, which thermo-crosslinking compound is a cyclical acid amide of the general formula :   see diagramm : EP0111273,P8,F1   wherein R denotes a hydrogen atom or an alkyl group.
Patent AU-719745-B2 (AU)
Title: Flat-top container with an opening fitment
Inventor: MOGARD JENS
IPC: B31B3/28
Filed: 1997-04-08
Granted: 2000-05-18
Abstract: A flat-top, hermetically sealed, paperboard-based container and apparatus and method of making it are set forth. The paperboard-based container includes a rectangular sleeve having upper end sections joined at fold lines with side walls. The upper end sections are divided into inner and outer opposed pairs which are folded toward one another in an overlapping manner to form a generally flat end for the container. Each of the inner and outer opposed sections includes a cutout. When the upper end sections are folded in and overlapping manner, the cutouts define an aperture having edges that include exposed paperboard substrate. Each of the inner pair of opposed end sections are divided along fold lines into a middle region and laterally opposed side regions. The laterally opposed side regions are folded onto the middle region and are sandwiched between the middle region and the outer pair of opposed sections when folded to form the container top. One of the outer pair of opposed upper end sections is longer than the other so that the longer outer end section overlaps exterior to the shorter of the outer pair of opposed upper end sections. An opening fitment is disposed through the aperture and includes a flange at the interior of the container. The flange covers the exposed edges of the aperture. The fitment is preferably a resealable cover, such as a resealable screw-type spout and cap or the like.
Patent AU-756099-B2 (AU)
Title: Method for controlling charging maneuvers in a hydroelectric installation with a surge tank
Inventor: DORFLER PETER KARL
IPC: F03B15/14
Filed: 2000-02-28
Granted: 2003-01-02
Abstract: The invention relates to a method for preventing unacceptable charging maneuvers in hydroelectric plants. Said method makes it possible to determine temporal progression of the level in a surge tank and to compare an existing state with a limit curve in a phase plane on the basis of an actual level (z) and a net inflow ( DELTA Q). Once the limit curve has been reached, the following charge increase is interrupted so that a given minimum or maximum value of the level in the surge tank cannot be exceeded.
Patent AU-684372-B2 (AU)
Title: Multi-layer containers
Inventor: SLAT WILLIAM A
IPC: B29C49/04
Filed: 1995-06-16
Granted: 1997-12-11
Abstract: A multi-layer preform for forming multi-layer containers includes an extruded upper portion having a first thickness which is adapted to form an upper portion of a container. The preform also includes an extruded intermediate portion having a second thickness thicker than the first thickness. The intermediate portion is connected with the upper portion and is adapted to form an intermediate body portion of the container. The preform also includes an extruded base portion having a third thickness thicker than the second thickness. The base portion is connected with the intermediate portion and is adapted form a base portion of the container. The portions of the preform are preferably formed from an inner layer and a barrier layer wherein the layers are co-extruded for forming the preform and an outer injection molded layer. In one embodiment, the inner layer includes a lip which overlaps the top edge of the barrier and outer layers. A multi-layer container is then formable from blow molding the preform.
Patent AU-630866-B2 (AU)
Title: Macrocyclic compounds
IPC: C07H19/01
Filed: 1988-12-02
Granted: 1992-11-12
Abstract: Compounds of formula I <CHEM> in which [R<1> and R<2>], [R<3> and R<4>] and [R<5> and R<6>] represent a carbon-carbon bond or two hydrogen atoms;  R<2> additionally represents alkyl;  R<7>, R<8> and R<9> represent groups including H or OH,  R<1><0> has various significances including alkyl and alkenyl;  X and Y represent groups including O and (H,OH); R<1><4>, R<1><5>, R<1><6>, R<1><7>, R<1><8>, R<1><9>, R<2><2> and R<2><3> represent H or alkyl; R<2><0> and R<2><1> represent groups including O, (H,OH) and (H,O-alkyl),  n is 1, 2, or 3, and in addition, Y, R<1><0> and R<2><3>, together with the carbon atoms to which they are attached, may represent a neterocyclic ring,  (with certain provisos) are described. Processes for making the compounds and pharmaceutical formulations containing them, eg for use as immunosuppressive agents, are also described.
Patent AU-659888-B2 (AU)
Title: A process for the preparation of 2-acetyl-1-pyrroline in encapsulated form, the intermediate compound and end product obtained
Inventor: DUBY PHILIPPE
IPC: A23L27/20
Filed: 1992-11-20
Granted: 1995-06-01
Abstract: Process for obtaining 2-acetyl-1-pyrroline which is in encapsulated form and the final product obtained, as well as the intermediate compound obtained and a use of this compound.
Patent AU-722557-B2 (AU)
Title: Detecting atherosclerosis in humans
Inventor: SHANKAR R
IPC: G06F19/00
Filed: 1999-05-18
Granted: 2000-08-03
Abstract: The present invention relates to a method for detecting the onset of atherosclerosis and for detecting the degree of atherosclerosis. Accordingly, one aspect of the present invention correlates data obtained from arteries having a measured amount of stenosis with actual arterial data (blood volume change vs. cuff pressure) obtained from a patient which is converted into data relating to the patient's arterial peak compliance. Another aspect of the present invention detects the onset and the degree of atherosclerosis by classifying the shape of a curve obtained by relating arterial blood volume change with cuff pressure. Two devices can be used, an electrical impedance plethysmograph and a volume plethysmograph.
Patent AU-612239-B2 (AU)
Title: Cast aluminium alloys
Inventor: EADY JOHN ALAN
IPC: C22F1/043
Filed: 1989-02-10
Granted: 1991-07-04
Abstract: A cast hypereutectic Al-Si alloy with from 12-15 % Si, having excellent wear resistance and machinability, improved fatigue strength and good levels of ambient and elevated temperature properties is provided, as well as a method of producing such alloy. The alloy and a melt used in the method contains Sr in excess of 0.10 % and Ti in excess of 0.005 %, the alloy further comprising: Cu 1.5 to 5.5 %, Ni 1.0 to 3.00 %, Mg 0.1 to 1.0 %, Fe 0.1 to 1.0 %, Mn 0.1 to 0.8 %, Zr 0.01 to 0.1 %, Zn 0 to 3.0 %, Sn 0 to 0.2 %, Pb 0 to 0.2 %, Cr 0 to 0.1 %, Na 0 to 0.01 %, B (elemental) 0.05 % maximum, Ca 0.003 % maximum, P 0.003 % maximum. Others 0.05 % maximum each, the balance, apart from incidental impurities, being Al. The level of Sr in excess of 0.10 % and Ti in excess of 0.005 % is such that the alloy has a microstructure in which any primary Si formed is substantially uniformly dispersed and is substantially free of segregation, and in which substantially uniformly dispersed Sr intermetallic particles are present but are substantially free of such particles in the form of platelets, with the microstructure predominantly comprising a eutectic matrix.
Patent AU-756983-B2 (AU)
Title: Novel opiate compounds, methods of making and methods of use
Inventor: CARROLL FRANK IVY
IPC: C07D211/58
Filed: 1999-03-09
Granted: 2003-01-30
Abstract: The present invention relates to a class of nitrogen-containing heterocyclic compounds which bind to opioid receptors. The inventive compounds can be used to treat a variety of disease states which involve the opioid receptors.
Patent AU-657829-B2 (AU)
Title: Adeno-associated virus-2 basal vectors
Inventor: SRIVASTAVA ARUN
IPC: A61P35/00
Filed: 1992-11-06
Granted: 1995-03-23
Abstract: Gene therapy involves the transfer and stable insertion of new genetic information into cells. The present invention is directed to safe vectors for gene therapy and thus provides hybrid parvovirus vectors which are capable of site-specific integration into a mammalian chromosome without substantial cytotoxicity, and which direct erythroid cell-specific expression of heterologous genes. The hybrid vector is useful in gene therapy, particularly in the treatment of hemoglobinopathies and other hematopoietic diseases. A method of delivery of constitutive levels of a pharmaceutical product and a method of producing a recombinant protein are also provided.
Patent AU-606840-B2 (AU)
Title: Transdermal multipolymer drug delivery system
Inventor: SABLOTSKY STEVEN
IPC: A61L15/18
Filed: 1989-02-21
Granted: 1991-02-14
Abstract: A dermal compositon comprising a drug, a multi-polymer of vinyl acetate, polyethylene and optionally one or more monomers, a natural or synthetic rubber and a tackifying agent. The ratio of the multipolymer to the rubber is, respectively, about 1:1 to about 10:1 and more preferably 1:1 to 5:1 and more preferably 3:1. The dermal composition can optionally contain a crosslinking agent, tackifiers, penetration enhancers and other ingredients known for use in adhesives for the transdermal delivery of drugs. The dermal compositions can be produced by a variety of methods known in the preparation of drug containing adhesive preparations including the homogenous mixing of the multi-polymer, drug and optional crosslinking agent and additional ingredients in aqueous solution followed by removal of excess water.
Patent AU-714929-B2 (AU)
Title: Modified thermostable DNA polymerase
Inventor: GELFAND DAVID HARROW
IPC: C12Q1/6848
Filed: 1997-08-06
Granted: 2000-01-13
Abstract: The invention provides thermostable DNA polymerase enzymes that comprises the amino acid sequence SerGlnIleXaaLeuArgXaa (SEQ ID NO: 1), wherein "Xaa" at position 4 of this sequence is any amino acid residue but not a glutamic acid residue (Glu), preferably a glycine residue and "Xaa" at position 7 of this sequence is a valine residue (Val) or an isoleucine residue (Ile). The thermostable DNA polymerases of the invention have enhanced efficiency for incorporating unconventional nucleotides, such as ribonucleotides, into DNA products and are advantageous in many in vitro synthesis applications. Such enzymes are particularly useful for use in nucleic acid sequencing protocols and provide novel means for DNA sequence analysis with cost and efficiency advantages. Also claimed are nucleic acids encoding said polymerases, vectors and hoste cells comprising such a nucleic acid, as well as compositions for use in a DNA sequencing reaction, kits and methods for sequencing including such polymerases.
Patent AU-687619-B2 (AU)
Title: Analog of haemophilus HIN47 with reduced protease activity
Inventor: LOOSMORE SHEENA M
IPC: C12N15/31
Filed: 1995-07-21
Granted: 1998-02-26
Abstract: An isolated and purified analog of Haemophilus influenza Hin47 protein has a decreased protease activity which is less than about 10% of that of natural Hin47 protein and preferably substantially the same immunogenic properties as natural Hin47 protein. An isolated and purified nucleic acid molecule encoding the Hin47 analog may be provided in a recombinant plasmid which may be introduced into a cell which is grown to produce the Hin47 analog. Immunogenic compositions comprising the Hin47 analog and the encoding nucleic acid may be formulated as vaccines for in vivo administration to a host, including a human, to confer protection against diseases caused by a bacterial pathogen, including Haemophilus species, such as Haemophilus influenzae, that produces Hin47 protein or a protein capable of inducing antibodies in the host specifically reactive with Hin47 protein. The Hin47 analog and the encoding nucleic acid also may be employed in diagnostic applications.